TRDAEntrada Therapeutics, Inc.
- Market cap
- $171.71M
- as of 2026-10-23
- Latest close
- $4.41
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-19
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Mpm Bioventures 2018 (B), L.P. | Sep 9 | Sep 9 | S | 28,837 | $7.13 | Sale −$205,608 | 3,885,115 | No | Form 4 |
| MPM BioVentures 2018 GP LLC | Sep 9 | Sep 9 | S | 28,837 | $7.13 | Sale −$205,608 | 3,885,115 | No | Form 4 |
| Mpm Bioventures 2018 (B), L.P. | Sep 8 | Sep 9 | S | 192,500 | $7.41 | Sale −$1,426,425 | 3,913,952 | No | Form 4 |
| MPM BioVentures 2018 GP LLC | Sep 8 | Sep 9 | S | 192,500 | $7.41 | Sale −$1,426,425 | 3,913,952 | No | Form 4 |
| Mpm Bioventures 2018 (B), L.P. | Sep 4 | Sep 9 | S | 38,500 | $7.11 | Sale −$273,735 | 4,106,452 | No | Form 4 |
| MPM BioVentures 2018 GP LLC | Sep 4 | Sep 9 | S | 38,500 | $7.11 | Sale −$273,735 | 4,106,452 | No | Form 4 |
| MPM BioVentures 2014 GP LLC | Sep 3 | Sep 3 | S | 32,263 | $7.17 | Sale −$231,326 | 4,144,952 | No | Form 4 |
| MPM BioVentures 2018 LLC | Sep 3 | Sep 3 | S | 32,263 | $7.17 | Sale −$231,326 | 4,144,952 | No | Form 4 |
| MPM BioVentures 2014 GP LLC | Sep 2 | Sep 3 | S | 25,131 | $7.19 | Sale −$180,692 | 4,177,215 | No | Form 4 |
| MPM BioVentures 2018 LLC | Sep 2 | Sep 3 | S | 25,131 | $7.19 | Sale −$180,692 | 4,177,215 | No | Form 4 |
| Doshi DipalCEO | Sep 2 | Sep 3 | F | 8,724 | $7.14 | $62,289 | 517,290 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 2 | Sep 3 | F | 1,733 | $7.14 | $12,374 | 117,277 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 2 | Sep 3 | F | 2,528 | $7.14 | $18,050 | 196,060 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Sep 2 | Sep 3 | F | 2,079 | $7.14 | $14,844 | 214,238 | No | Form 4 |
| MPM BioVentures 2014 GP LLC | Sep 1 | Sep 3 | S | 29,088 | $7.06 | Sale −$205,361 | 4,202,346 | No | Form 4 |
| MPM BioVentures 2018 LLC | Sep 1 | Sep 3 | S | 29,088 | $7.06 | Sale −$205,361 | 4,202,346 | No | Form 4 |
| MPM BioVentures 2014 (B), L.P. | Aug 31 | Aug 31 | S | 44,259 | $6.99 | Sale −$309,370 | 4,231,434 | No | Form 4 |
| MPM BioVentures 2018 LLC | Aug 31 | Aug 31 | S | 44,259 | $6.99 | Sale −$309,370 | 4,231,434 | No | Form 4 |
| MPM BioVentures 2014 (B), L.P. | Aug 28 | Aug 31 | S | 3,733 | $7.01 | Sale −$26,168 | 4,275,693 | No | Form 4 |
| MPM BioVentures 2018 LLC | Aug 28 | Aug 31 | S | 3,733 | $7.01 | Sale −$26,168 | 4,275,693 | No | Form 4 |
| MPM BioVentures 2014 (B), L.P. | Aug 27 | Aug 31 | S | 38,922 | $7.20 | Sale −$280,238 | 4,279,426 | No | Form 4 |
| MPM BioVentures 2018 LLC | Aug 27 | Aug 31 | S | 38,922 | $7.20 | Sale −$280,238 | 4,279,426 | No | Form 4 |
| MPM BioVentures 2018 LLC | Aug 26 | Aug 26 | S | 14,569 | $7.06 | Sale −$102,857 | 4,318,348 | No | Form 4 |
| Foley Todd | Aug 26 | Aug 26 | S | 14,569 | $7.06 | Sale −$102,857 | 4,318,348 | No | Form 4 |
| MPM BioVentures 2018 LLC | Aug 25 | Aug 26 | S | 26,522 | $7.54 | Sale −$199,976 | 4,332,917 | No | Form 4 |
| Foley Todd | Aug 25 | Aug 26 | S | 26,522 | $7.54 | Sale −$199,976 | 4,332,917 | No | Form 4 |
| MPM BioVentures 2018 LLC | Aug 24 | Aug 26 | S | 21,623 | $7.34 | Sale −$158,713 | 4,359,439 | No | Form 4 |
| Foley Todd | Aug 24 | Aug 26 | S | 21,623 | $7.34 | Sale −$158,713 | 4,359,439 | No | Form 4 |
| Parmar Kush | Aug 10 | Aug 10 | S | 92,444 | $7.00 | Sale −$647,108 | 2,691,337 | No | Form 4 |
| Rocklage Scott M | Aug 7 | Aug 10 | S | 52,317 | $6.85 | Sale −$358,371 | 2,783,781 | No | Form 4 |
| Parmar Kush | Aug 7 | Aug 10 | S | 52,317 | $6.85 | Sale −$358,371 | 2,783,781 | No | Form 4 |
| Rocklage Scott M | Aug 6 | Aug 10 | S | 10,494 | $7.00 | Sale −$73,458 | 2,836,098 | No | Form 4 |
| Parmar Kush | Aug 6 | Aug 10 | S | 10,494 | $7.00 | Sale −$73,458 | 2,836,098 | No | Form 4 |
| Rocklage Scott M | Jul 31 | Aug 3 | S | 1,718 | $6.85 | Sale −$11,768 | 2,846,592 | No | Form 4 |
| Parmar Kush | Jul 31 | Aug 3 | S | 1,718 | $6.85 | Sale −$11,768 | 2,846,592 | No | Form 4 |
| Rocklage Scott M | Jul 30 | Aug 3 | S | 114,756 | $6.93 | Sale −$795,259 | 2,848,310 | No | Form 4 |
| Parmar Kush | Jul 30 | Aug 3 | S | 114,756 | $6.93 | Sale −$795,259 | 2,848,310 | No | Form 4 |
| Zeiher Bernhardt G | Jun 10 | Jun 12 | A · derivative | 19,000 | $5.97 | $113,430 | 19,000 | No | Form 4 |
| Thistle Mary | Jun 10 | Jun 12 | A · derivative | 19,000 | $5.97 | $113,430 | 19,000 | No | Form 4 |
| Chapman Gina | Jun 10 | Jun 12 | A · derivative | 19,000 | $5.97 | $113,430 | 19,000 | No | Form 4 |
| Kim Peter S | Jun 10 | Jun 12 | A · derivative | 19,000 | $5.97 | $113,430 | 19,000 | No | Form 4 |
| Parmar Kush | Jun 10 | Jun 12 | A · derivative | 19,000 | $5.97 | $113,430 | 19,000 | No | Form 4 |
| Radhakrishnan Maha | Jun 10 | Jun 12 | A · derivative | 19,000 | $5.97 | $113,430 | 19,000 | No | Form 4 |
| Zeiher Bernhardt G | May 20 | May 21 | P | 5,000 | $5.86 | Purchase +$29,300 | 5,000 | No | Form 4 |
| Dowden Nathan JPresident & COO | May 4 | May 4 | M | 15,000 | $1.74 | $26,100 | 213,588 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | May 4 | May 4 | S | 15,000 | $15.33 | Sale −$229,950 | 198,588 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | May 4 | May 4 | M · derivative | 15,000 | $1.74 | $26,100 | 49,831 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | May 4 | May 4 | S | 25,907 | $15.39 | Sale −$398,709 | 216,317 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Apr 1 | Apr 2 | S | 2,500 | $12.95 | Sale −$32,375 | 119,010 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 10 | Mar 11 | S | 11,388 | $13.02 | Sale −$148,272 | 121,510 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Mar 10 | Mar 11 | S | 11,894 | $13.05 | Sale −$155,217 | 198,588 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 9 | Mar 11 | S | 5,089 | $13.00 | Sale −$66,157 | 132,898 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Mar 9 | Mar 11 | S | 3,116 | $13.02 | Sale −$40,570 | 210,482 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 4 | Mar 6 | S | 7,988 | $12.25 | Sale −$97,853 | 137,987 | Yes | Form 4 |
| Doshi DipalCEO | Mar 3 | Mar 3 | F | 19,181 | $11.76 | $225,569 | 526,014 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 3 | Mar 3 | F | 5,712 | $11.76 | $67,173 | 145,975 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 3 | Mar 3 | F | 14,038 | $11.76 | $165,087 | 213,598 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 3 | Mar 3 | F | 7,577 | $11.76 | $89,106 | 242,224 | No | Form 4 |
| Doshi DipalCEO | Mar 2 | Mar 3 | F | 9,869 | $11.66 | $115,073 | 545,195 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 2 | Mar 3 | F | 2,939 | $11.66 | $34,269 | 151,687 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 2 | Mar 3 | F | 7,223 | $11.66 | $84,220 | 227,636 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 2 | Mar 3 | F | 3,898 | $11.66 | $45,451 | 249,801 | No | Form 4 |
| Doshi DipalCEO | Mar 1 | Mar 3 | A | 139,400 | $0.00 | $0 | 555,064 | No | Form 4 |
| Doshi DipalCEO | Mar 1 | Mar 3 | A · derivative | 208,000 | $11.93 | $2,481,440 | 208,000 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 1 | Mar 3 | A | 44,600 | $0.00 | $0 | 154,626 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 1 | Mar 3 | A · derivative | 66,600 | $11.93 | $794,538 | 66,600 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1 | Mar 3 | A | 55,800 | $0.00 | $0 | 234,859 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1 | Mar 3 | A · derivative | 83,200 | $11.93 | $992,576 | 83,200 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 1 | Mar 3 | A | 55,800 | $0.00 | $0 | 253,699 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 1 | Mar 3 | A · derivative | 83,200 | $11.93 | $992,576 | 83,200 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 21, 2025 | Nov 24, 2025 | S | 8,910 | $9.98 | Sale −$88,922 | 110,026 | Yes | Form 4 |
| Baker Felix | Nov 20, 2025 | Nov 24, 2025 | P | 1,213 | $9.07 | Purchase +$11,002 | 380,152 | No | Form 4 |
| Baker Felix | Nov 20, 2025 | Nov 24, 2025 | P | 13,386 | $9.07 | Purchase +$121,411 | 4,678,310 | No | Form 4 |
| Baker Felix | Nov 20, 2025 | Nov 24, 2025 | P | 1,186 | $9.07 | Purchase +$10,757 | 381,338 | No | Form 4 |
| Baker Felix | Nov 20, 2025 | Nov 24, 2025 | P | 13,082 | $9.07 | Purchase +$118,654 | 4,691,392 | No | Form 4 |
| 5AM Ventures V, L.P. | Nov 14, 2025 | Nov 18, 2025 | S | 200,000 | $8.80 | Sale −$1,760,000 | 2,963,066 | No | Form 4 |
| Parmar Kush | Nov 14, 2025 | Nov 18, 2025 | S | 200,000 | $8.80 | Sale −$1,760,000 | 2,963,066 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 12, 2025 | Nov 12, 2025 | P | 7,321 | $7.73 | Purchase +$56,591 | 377,899 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 12, 2025 | Nov 12, 2025 | P | 80,881 | $7.73 | Purchase +$625,210 | 4,653,430 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 12, 2025 | Nov 12, 2025 | P | 1,040 | $7.95 | Purchase +$8,268 | 378,939 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 12, 2025 | Nov 12, 2025 | P | 11,494 | $7.95 | Purchase +$91,377 | 4,664,924 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 11, 2025 | Nov 12, 2025 | P | 1,059 | $7.39 | Purchase +$7,826 | 367,783 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 11, 2025 | Nov 12, 2025 | P | 11,701 | $7.39 | Purchase +$86,470 | 4,541,670 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 11, 2025 | Nov 12, 2025 | P | 2,795 | $7.54 | Purchase +$21,074 | 370,578 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 11, 2025 | Nov 12, 2025 | P | 30,879 | $7.54 | Purchase +$232,828 | 4,572,549 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 10, 2025 | Nov 12, 2025 | P | 2,296 | $7.21 | Purchase +$16,554 | 366,457 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 10, 2025 | Nov 12, 2025 | P | 25,364 | $7.21 | Purchase +$182,874 | 4,527,022 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 10, 2025 | Nov 12, 2025 | P | 267 | $7.22 | Purchase +$1,928 | 366,724 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Nov 10, 2025 | Nov 12, 2025 | P | 2,947 | $7.22 | Purchase +$21,277 | 4,529,969 | No | Form 4 |
| Doshi DipalCEO | Sep 2, 2025 | Sep 4, 2025 | F | 8,723 | $5.43 | $47,366 | 415,664 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 2, 2025 | Sep 4, 2025 | F | 1,734 | $5.43 | $9,416 | 118,936 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 2, 2025 | Sep 4, 2025 | F | 1,746 | $5.43 | $9,481 | 179,059 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Sep 2, 2025 | Sep 4, 2025 | F | 1,760 | $5.43 | $9,557 | 197,899 | No | Form 4 |
| 5AM Opportunities I, L.P. | Jul 9, 2025 | Jul 11, 2025 | S | 20,065 | $7.50 | Sale −$150,488 | 3,163,066 | No | Form 4 |
| 5AM Opportunities I, L.P. | Jul 9, 2025 | Jul 11, 2025 | S | 6,935 | $7.50 | Sale −$52,013 | 1,093,313 | No | Form 4 |
| Parmar Kush | Jul 9, 2025 | Jul 11, 2025 | S | 20,065 | $7.50 | Sale −$150,488 | 3,163,066 | No | Form 4 |
| Parmar Kush | Jul 9, 2025 | Jul 11, 2025 | S | 6,935 | $7.50 | Sale −$52,013 | 1,093,313 | No | Form 4 |
| Schwab Andrew J. | Jul 1, 2025 | Jul 1, 2025 | S | 18,578 | $7.12 | Sale −$132,275 | 3,183,131 | No | Form 4 |
| Schwab Andrew J. | Jul 1, 2025 | Jul 1, 2025 | S | 6,422 | $7.12 | Sale −$45,725 | 1,100,248 | No | Form 4 |
| Parmar Kush | Jul 1, 2025 | Jul 1, 2025 | S | 18,578 | $7.12 | Sale −$132,275 | 3,183,131 | No | Form 4 |
| Parmar Kush | Jul 1, 2025 | Jul 1, 2025 | S | 6,422 | $7.12 | Sale −$45,725 | 1,100,248 | No | Form 4 |
| Schwab Andrew J. | Jun 30, 2025 | Jul 1, 2025 | S | 18,578 | $6.81 | Sale −$126,516 | 3,201,709 | No | Form 4 |
| Schwab Andrew J. | Jun 30, 2025 | Jul 1, 2025 | S | 6,422 | $6.81 | Sale −$43,734 | 1,106,670 | No | Form 4 |
| Parmar Kush | Jun 30, 2025 | Jul 1, 2025 | S | 18,578 | $6.81 | Sale −$126,516 | 3,201,709 | No | Form 4 |
| Parmar Kush | Jun 30, 2025 | Jul 1, 2025 | S | 6,422 | $6.81 | Sale −$43,734 | 1,106,670 | No | Form 4 |
| Schwab Andrew J. | Jun 27, 2025 | Jul 1, 2025 | S | 55,735 | $6.91 | Sale −$385,129 | 3,220,287 | No | Form 4 |
| Schwab Andrew J. | Jun 27, 2025 | Jul 1, 2025 | S | 19,265 | $6.91 | Sale −$133,121 | 1,113,092 | No | Form 4 |
| Parmar Kush | Jun 27, 2025 | Jul 1, 2025 | S | 55,735 | $6.91 | Sale −$385,129 | 3,220,287 | No | Form 4 |
| Parmar Kush | Jun 27, 2025 | Jul 1, 2025 | S | 19,265 | $6.91 | Sale −$133,121 | 1,113,092 | No | Form 4 |
| Kim Peter S | May 14, 2024 | Jun 18, 20254/A | P | 25,000 | $14.59 | Purchase +$364,750 | 117,412 | No | Form 4/A |
| Kim Peter S | May 13, 2024 | Jun 18, 20254/A | P | 25,000 | $14.68 | Purchase +$367,000 | 92,412 | No | Form 4/A |
| Chapman Gina | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 19,000 | $7.90 | $150,100 | 19,000 | No | Form 4 |
| Zeiher Bernhardt G | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 19,000 | $7.90 | $150,100 | 19,000 | No | Form 4 |
| Thistle Mary | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 19,000 | $7.90 | $150,100 | 19,000 | No | Form 4 |
| Kim Peter S | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 19,000 | $7.90 | $150,100 | 19,000 | No | Form 4 |
| Parmar Kush | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 19,000 | $7.90 | $150,100 | 19,000 | No | Form 4 |
| Radhakrishnan Maha | Jun 1, 2025 | Jun 3, 2025 | A · derivative | 38,000 | $7.60 | $288,800 | 38,000 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Apr 3, 2025 | Apr 4, 2025 | M | 11,134 | $2.10 | $23,381 | 120,670 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Apr 3, 2025 | Apr 4, 2025 | M · derivative | 11,134 | $2.10 | $23,381 | 20,023 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 17, 2025 | Mar 19, 2025 | S | 1,784 | $10.67 | Sale −$19,035 | 109,536 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 3, 2025 | Mar 4, 2025 | F | 6,138 | $11.68 | $71,692 | 199,659 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 3, 2025 | Mar 4, 2025 | F | 5,144 | $11.68 | $60,082 | 180,805 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 3, 2025 | Mar 4, 2025 | F | 4,929 | $11.68 | $57,571 | 111,320 | No | Form 4 |
| Doshi DipalCEO | Mar 3, 2025 | Mar 4, 2025 | F | 17,566 | $11.68 | $205,171 | 424,387 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 1, 2025 | Mar 4, 2025 | A | 60,800 | $0.00 | $0 | 205,797 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Mar 1, 2025 | Mar 4, 2025 | A · derivative | 90,800 | $11.94 | $1,084,152 | 90,800 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1, 2025 | Mar 4, 2025 | A | 60,800 | $0.00 | $0 | 185,949 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1, 2025 | Mar 4, 2025 | A · derivative | 90,800 | $11.94 | $1,084,152 | 90,800 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 1, 2025 | Mar 4, 2025 | A | 42,400 | $0.00 | $0 | 116,249 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 1, 2025 | Mar 4, 2025 | A · derivative | 63,300 | $11.94 | $755,802 | 63,300 | No | Form 4 |
| Doshi DipalCEO | Mar 1, 2025 | Mar 4, 2025 | A | 116,200 | $0.00 | $0 | 441,953 | No | Form 4 |
| Doshi DipalCEO | Mar 1, 2025 | Mar 4, 2025 | A · derivative | 173,400 | $11.94 | $2,070,396 | 173,400 | No | Form 4 |
| Mpm Asset Management Investors BV2018 LLC | Dec 11, 2024 | Dec 12, 2024 | S | 21,787 | $20.23 | Sale −$440,751 | 4,381,062 | No | Form 4 |
| MPM BioVentures 2018 GP LLC | Dec 11, 2024 | Dec 12, 2024 | S | 21,787 | $20.23 | Sale −$440,751 | 4,381,062 | No | Form 4 |
| Mpm Asset Management Investors BV2018 LLC | Dec 10, 2024 | Dec 12, 2024 | S | 22,935 | $20.77 | Sale −$476,360 | 4,402,849 | No | Form 4 |
| MPM BioVentures 2018 GP LLC | Dec 10, 2024 | Dec 12, 2024 | S | 22,935 | $20.77 | Sale −$476,360 | 4,402,849 | No | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Dec 3, 2024 | Dec 3, 2024 | S | 11,703 | $20.15 | Sale −$235,815 | 144,997 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Dec 2, 2024 | Dec 3, 2024 | S | 4,088 | $20.26 | Sale −$82,823 | 156,700 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 2, 2024 | Dec 3, 2024 | M | 5,000 | $2.10 | $10,500 | 78,849 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 2, 2024 | Dec 3, 2024 | S | 5,000 | $20.00 | Sale −$100,000 | 73,849 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 2, 2024 | Dec 3, 2024 | M · derivative | 5,000 | $2.10 | $10,500 | 31,157 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 29, 2024 | Dec 3, 2024 | S | 100 | $20.00 | Sale −$2,000 | 160,788 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 29, 2024 | Dec 3, 2024 | M | 1,000 | $2.10 | $2,100 | 74,849 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 29, 2024 | Dec 3, 2024 | S | 1,000 | $19.97 | Sale −$19,970 | 73,849 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 29, 2024 | Dec 3, 2024 | M · derivative | 1,000 | $2.10 | $2,100 | 36,157 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 13, 2024 | Nov 13, 2024 | S | 2,700 | $20.04 | Sale −$54,108 | 160,888 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 11, 2024 | Nov 13, 2024 | M | 6,000 | $2.10 | $12,600 | 82,486 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 11, 2024 | Nov 13, 2024 | S | 8,637 | $19.98 | Sale −$172,567 | 73,849 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Nov 11, 2024 | Nov 13, 2024 | M · derivative | 6,000 | $2.10 | $12,600 | 37,157 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 11, 2024 | Nov 13, 2024 | S | 1,409 | $20.01 | Sale −$28,194 | 163,588 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 6, 2024 | Nov 6, 2024 | S | 9,554 | $18.71 | Sale −$178,755 | 167,742 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 6, 2024 | Nov 6, 2024 | S | 2,745 | $19.32 | Sale −$53,033 | 164,997 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 5, 2024 | Nov 6, 2024 | S | 5,171 | $18.18 | Sale −$94,009 | 177,296 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Nov 4, 2024 | Nov 6, 2024 | S | 749 | $18.02 | Sale −$13,497 | 182,467 | Yes | Form 4 |
| Sethuraman NatarajanPresident, Research & Develop. | Oct 16, 2024 | Oct 18, 2024 | S | 600 | $18.00 | Sale −$10,800 | 183,216 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Sep 26, 2024 | Sep 30, 2024 | S | 847 | $16.00 | Sale −$13,552 | 125,149 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 9, 2024 | Sep 10, 2024 | S | 2,642 | $15.09 | Sale −$39,868 | 183,816 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Sep 9, 2024 | Sep 10, 2024 | S | 1,904 | $15.07 | Sale −$28,693 | 125,996 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 9, 2024 | Sep 10, 2024 | S | 3,195 | $14.97 | Sale −$47,829 | 76,486 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 6, 2024 | Sep 10, 2024 | S | 600 | $15.24 | Sale −$9,144 | 186,458 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Sep 6, 2024 | Sep 10, 2024 | S | 399 | $15.19 | Sale −$6,061 | 127,900 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 5, 2024 | Sep 5, 2024 | F | 165 | $15.13 | $2,496 | 79,681 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 5, 2024 | Sep 5, 2024 | F | 167 | $15.13 | $2,527 | 187,058 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 5, 2024 | Sep 5, 2024 | F | 171 | $15.13 | $2,587 | 128,299 | No | Form 4 |
| Doshi DipalCEO | Sep 5, 2024 | Sep 5, 2024 | F | 826 | $15.13 | $12,497 | 325,753 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 4, 2024 | Sep 5, 2024 | F | 941 | $15.42 | $14,510 | 79,846 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 4, 2024 | Sep 5, 2024 | F | 955 | $15.42 | $14,726 | 187,225 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 4, 2024 | Sep 5, 2024 | F | 983 | $15.42 | $15,158 | 128,470 | No | Form 4 |
| Doshi DipalCEO | Sep 4, 2024 | Sep 5, 2024 | F | 4,744 | $15.42 | $73,152 | 326,579 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 3, 2024 | Sep 5, 2024 | F | 462 | $15.76 | $7,281 | 80,950 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 3, 2024 | Sep 5, 2024 | F | 149 | $16.93 | $2,523 | 80,801 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Sep 3, 2024 | Sep 5, 2024 | F | 14 | $17.70 | $248 | 80,787 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 3, 2024 | Sep 5, 2024 | F | 469 | $15.76 | $7,391 | 188,345 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 3, 2024 | Sep 5, 2024 | F | 151 | $16.93 | $2,556 | 188,194 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Sep 3, 2024 | Sep 5, 2024 | F | 14 | $17.70 | $248 | 188,180 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 3, 2024 | Sep 5, 2024 | F | 483 | $15.76 | $7,612 | 129,624 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 3, 2024 | Sep 5, 2024 | F | 156 | $16.93 | $2,641 | 129,468 | No | Form 4 |
| Dowden Nathan JPresident & COO | Sep 3, 2024 | Sep 5, 2024 | F | 15 | $17.70 | $266 | 129,453 | No | Form 4 |
| Doshi DipalCEO | Sep 3, 2024 | Sep 5, 2024 | F | 2,328 | $15.76 | $36,689 | 332,147 | No | Form 4 |
| Doshi DipalCEO | Sep 3, 2024 | Sep 5, 2024 | F | 752 | $16.93 | $12,731 | 331,395 | No | Form 4 |
| Doshi DipalCEO | Sep 3, 2024 | Sep 5, 2024 | F | 72 | $17.70 | $1,274 | 331,323 | No | Form 4 |
| Dowden Nathan JPresident & COO | Aug 16, 2024 | Aug 20, 2024 | M | 20,000 | $1.74 | $34,800 | 157,204 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Aug 16, 2024 | Aug 20, 2024 | S | 26,595 | $16.26 | Sale −$432,435 | 130,609 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Aug 16, 2024 | Aug 20, 2024 | S | 502 | $16.70 | Sale −$8,383 | 130,107 | Yes | Form 4 |
| Dowden Nathan JPresident & COO | Aug 16, 2024 | Aug 20, 2024 | M · derivative | 20,000 | $1.74 | $34,800 | 64,831 | Yes | Form 4 |
| Doshi DipalCEO | Jul 15, 2024 | Jul 16, 2024 | S | 1,600 | $17.81 | Sale −$28,496 | 334,475 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Jul 15, 2024 | Jul 16, 2024 | S | 638 | $18.00 | Sale −$11,484 | 188,814 | Yes | Form 4 |
| Doshi DipalCEO | Jul 12, 2024 | Jul 16, 2024 | S | 300 | $18.00 | Sale −$5,400 | 336,075 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Jul 12, 2024 | Jul 16, 2024 | S | 600 | $18.00 | Sale −$10,800 | 189,452 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Jul 8, 2024 | Jul 10, 2024 | S | 1,758 | $14.95 | Sale −$26,282 | 81,412 | Yes | Form 4 |
| Baker Bros. Advisors LP | Jun 25, 2024 | Jun 26, 2024 | P · derivative | 285,700 | $14.85 | Purchase +$4,242,645 | 285,700 | No | Form 4 |
| Baker Bros. Advisors LP | Jun 25, 2024 | Jun 26, 2024 | P · derivative | 3,081,303 | $14.85 | Purchase +$45,757,350 | 3,081,303 | No | Form 4 |
| Doshi DipalCEO | Jun 13, 2024 | Jun 14, 2024 | S | 1,000 | $16.17 | Sale −$16,170 | 336,375 | Yes | Form 4 |
| Chapman Gina | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $16.45 | $263,200 | 16,000 | No | Form 4 |
| Zeiher Bernhardt G | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $16.45 | $263,200 | 16,000 | No | Form 4 |
| Thistle Mary | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $16.45 | $263,200 | 16,000 | No | Form 4 |
| Kim Peter S | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $16.45 | $263,200 | 16,000 | No | Form 4 |
| Parmar Kush | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 16,000 | $16.45 | $263,200 | 16,000 | No | Form 4 |
| Kim Peter S | Jun 3, 2024 | Jun 5, 2024 | M | 11,918 | $6.06 | $72,223 | 104,330 | No | Form 4 |
| Kim Peter S | Jun 3, 2024 | Jun 5, 2024 | M · derivative | 11,918 | $6.06 | $72,223 | not reported | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | May 20, 2024 | May 20, 2024 | S | 9,675 | $15.19 | Sale −$146,963 | 190,052 | Yes | Form 4 |
| Doshi DipalCEO | May 17, 2024 | May 20, 2024 | S | 1,200 | $15.11 | Sale −$18,132 | 337,375 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | May 17, 2024 | May 20, 2024 | S | 8,305 | $15.14 | Sale −$125,738 | 199,727 | Yes | Form 4 |
| Doshi DipalCEO | May 16, 2024 | May 20, 2024 | S | 1,800 | $15.00 | Sale −$27,000 | 338,575 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | May 16, 2024 | May 20, 2024 | S | 1,000 | $15.00 | Sale −$15,000 | 208,032 | Yes | Form 4 |
| Kim Peter S | May 14, 2024 | May 16, 2024 | P | 25,000 | $14.59 | Purchase +$364,750 | 92,412 | No | Form 4 |
| Kim Peter S | May 9, 2024 | May 10, 2024 | P | 2,200 | $14.25 | Purchase +$31,350 | 67,412 | No | Form 4 |
| Kim Peter S | May 8, 2024 | May 10, 2024 | P | 2,276 | $14.04 | Purchase +$31,955 | 65,212 | No | Form 4 |
| Kim Peter S | Apr 8, 2024 | Apr 10, 2024 | P | 2,600 | $13.57 | Purchase +$35,282 | 62,936 | No | Form 4 |
| Kim Peter S | Mar 28, 2024 | Apr 1, 2024 | P | 1,512 | $13.75 | Purchase +$20,790 | 60,336 | No | Form 4 |
| Kim Peter S | Mar 26, 2024 | Mar 26, 2024 | P | 2,750 | $13.64 | Purchase +$37,510 | 58,824 | No | Form 4 |
| Kim Peter S | Mar 25, 2024 | Mar 26, 2024 | P | 3,180 | $13.36 | Purchase +$42,485 | 56,074 | No | Form 4 |
| Kim Peter S | Mar 22, 2024 | Mar 26, 2024 | P | 3,118 | $13.76 | Purchase +$42,904 | 52,894 | No | Form 4 |
| Kim Peter S | Mar 21, 2024 | Mar 21, 2024 | P | 704 | $13.24 | Purchase +$9,321 | 49,776 | No | Form 4 |
| Kim Peter S | Mar 20, 2024 | Mar 21, 2024 | P | 1,128 | $12.66 | Purchase +$14,280 | 49,072 | No | Form 4 |
| Kim Peter S | Mar 19, 2024 | Mar 21, 2024 | P | 900 | $12.66 | Purchase +$11,394 | 47,944 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 15, 2024 | Mar 19, 2024 | M | 9,000 | $2.10 | $18,900 | 83,170 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 9,000 | $2.10 | $18,900 | 43,157 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 6, 2024 | Mar 8, 2024 | S | 1,826 | $12.32 | Sale −$22,496 | 137,204 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 6, 2024 | Mar 8, 2024 | S | 4,086 | $12.31 | Sale −$50,299 | 74,170 | Yes | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Mar 5, 2024 | Mar 5, 2024 | F | 1,505 | $12.28 | $18,481 | 209,032 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 5, 2024 | Mar 5, 2024 | F | 1,486 | $12.28 | $18,248 | 139,030 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 5, 2024 | Mar 5, 2024 | F | 1,471 | $12.28 | $18,064 | 78,256 | No | Form 4 |
| Doshi DipalCEO | Mar 5, 2024 | Mar 5, 2024 | F | 5,049 | $12.28 | $62,002 | 340,375 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Mar 4, 2024 | Mar 5, 2024 | F | 347 | $12.42 | $4,310 | 210,951 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Mar 4, 2024 | Mar 5, 2024 | F | 414 | $13.37 | $5,535 | 210,537 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 4, 2024 | Mar 5, 2024 | F | 343 | $12.42 | $4,260 | 140,925 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 4, 2024 | Mar 5, 2024 | F | 409 | $13.37 | $5,468 | 140,516 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 4, 2024 | Mar 5, 2024 | F | 339 | $12.42 | $4,210 | 80,132 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 4, 2024 | Mar 5, 2024 | F | 405 | $13.37 | $5,415 | 79,727 | No | Form 4 |
| Doshi DipalCEO | Mar 4, 2024 | Mar 5, 2024 | F | 1,164 | $12.42 | $14,457 | 346,815 | No | Form 4 |
| Doshi DipalCEO | Mar 4, 2024 | Mar 5, 2024 | F | 1,391 | $13.37 | $18,598 | 345,424 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Mar 1, 2024 | Mar 5, 2024 | A | 44,100 | $0.00 | $0 | 211,298 | No | Form 4 |
| Sethuraman NatarajanChief Scientific Officer | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 66,800 | $13.73 | $917,164 | 66,800 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1, 2024 | Mar 5, 2024 | A | 33,100 | $0.00 | $0 | 81,268 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1, 2024 | Mar 5, 2024 | A | 60,000 | $0.00 | $0 | 141,268 | No | Form 4 |
| Dowden Nathan JPresident & COO | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 50,100 | $13.73 | $687,873 | 50,100 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 1, 2024 | Mar 5, 2024 | A | 30,900 | $0.00 | $0 | 80,471 | No | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 46,800 | $13.73 | $642,564 | 46,800 | No | Form 4 |
| Doshi DipalCEO | Mar 1, 2024 | Mar 5, 2024 | A | 104,700 | $0.00 | $0 | 347,979 | No | Form 4 |
| Doshi DipalCEO | Mar 1, 2024 | Mar 5, 2024 | A · derivative | 158,500 | $13.73 | $2,176,205 | 158,500 | No | Form 4 |
| Doshi DipalCEO | Feb 15, 2024 | Feb 20, 2024 | S | 1,000 | $15.00 | Sale −$15,000 | 243,279 | Yes | Form 4 |
| Doshi DipalCEO | Jan 16, 2024 | Jan 18, 2024 | S | 1,000 | $15.99 | Sale −$15,990 | 244,279 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 26, 2023 | Dec 26, 2023 | M | 94 | $2.10 | $197 | 49,665 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 26, 2023 | Dec 26, 2023 | S | 94 | $16.67 | Sale −$1,567 | 49,571 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 26, 2023 | Dec 26, 2023 | M · derivative | 94 | $2.10 | $197 | 52,157 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 22, 2023 | Dec 26, 2023 | M | 10,206 | $2.10 | $21,433 | 59,777 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 22, 2023 | Dec 26, 2023 | S | 6,529 | $15.24 | Sale −$99,502 | 53,248 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 22, 2023 | Dec 26, 2023 | S | 3,677 | $16.48 | Sale −$60,597 | 49,571 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 22, 2023 | Dec 26, 2023 | M · derivative | 10,206 | $2.10 | $21,433 | 52,251 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 21, 2023 | Dec 26, 2023 | M | 2,200 | $2.10 | $4,620 | 51,771 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 21, 2023 | Dec 26, 2023 | S | 2,200 | $15.07 | Sale −$33,154 | 49,571 | Yes | Form 4 |
| Wentworth Kory JamesChief Financial Officer | Dec 21, 2023 | Dec 26, 2023 | M · derivative | 2,200 | $2.10 | $4,620 | 62,457 | Yes | Form 4 |
| Doshi DipalPresident and CEO | Dec 20, 2023 | Dec 22, 2023 | S | 1,000 | $15.00 | Sale −$15,000 | 245,279 | Yes | Form 4 |
| Doshi DipalPresident and CEO | Nov 13, 2023 | Nov 13, 2023 | S | 1,000 | $16.23 | Sale −$16,230 | 246,279 | Yes | Form 4 |
| Doshi DipalPresident and CEO | Oct 17, 2023 | Oct 19, 2023 | S | 1,000 | $15.00 | Sale −$15,000 | 247,279 | Yes | Form 4 |